These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Real-World Data on: Attention Deficit Hyperactivity Disorder Medication Side Effects. Cascade E; Kalali AH; Wigal SB Psychiatry (Edgmont); 2010 Apr; 7(4):13-5. PubMed ID: 20508803 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404 [TBL] [Abstract][Full Text] [Related]
26. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437 [TBL] [Abstract][Full Text] [Related]
27. Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder. Silva RR; Brams M; McCague K; Pestreich L; Muniz R Clin Neuropharmacol; 2013; 36(4):117-21. PubMed ID: 23860345 [TBL] [Abstract][Full Text] [Related]
28. Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. Castells X; Cunill R; Capellà D Eur J Clin Pharmacol; 2013 Mar; 69(3):347-56. PubMed ID: 22983311 [TBL] [Abstract][Full Text] [Related]
29. Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate. Childress AC; Cutler AJ; Patel M; Oh C J Child Adolesc Psychopharmacol; 2023 May; 33(4):134-142. PubMed ID: 37204277 [No Abstract] [Full Text] [Related]
30. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder. Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Spencer TJ; Adler LA; McGough JJ; Muniz R; Jiang H; Pestreich L; Biol Psychiatry; 2007 Jun; 61(12):1380-7. PubMed ID: 17137560 [TBL] [Abstract][Full Text] [Related]